-
Je něco špatně v tomto záznamu ?
The fat mass and obesity related gene polymorphism influences the risk of rejection in heart transplant patients
JA. Hubacek, J. Vymetalova, V. Lanska, D. Dlouha,
Jazyk angličtina Země Dánsko
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
30408245
DOI
10.1111/ctr.13443
Knihovny.cz E-zdroje
- MeSH
- gen pro FTO genetika MeSH
- genotyp MeSH
- jednonukleotidový polymorfismus * MeSH
- lidé středního věku MeSH
- lidé MeSH
- následné studie MeSH
- pooperační komplikace diagnóza etiologie genetika MeSH
- přežívání štěpu MeSH
- prognóza MeSH
- rejekce štěpu diagnóza etiologie genetika MeSH
- rizikové faktory MeSH
- transplantace srdce škodlivé účinky MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Heart transplantation is a relatively common treatment for end-stage heart failure. The major complication of heart transplantation is organ rejection. Epigenetic could play a role in the pathogenesis of organ rejection, and the FTO gene is a mediator of DNA methylation. We analyzed a tagging FTO SNP rs17817449 in both donor and recipient DNA obtained through 370 heart transplantations. Recipient FTO genotypes were not associated with either type of rejection or with the general increase in the risk of rejection. When compared with patients without a history of rejection, carriers of transplanted hearts with the FTO TT genotype exhibited a significantly increased risk (P = 0.02) of suffering from both types of rejection in comparison to carriers of hearts with at least one G allele (OR; 95% CI = 2.56; 1.15-5.69). Our results suggest that the donor, but not the recipient, FTO genotype could be a significant predictor of acute rejection in heart transplant patients.
Cardio Centre Institute for Clinical and Experimental Medicine Prague Czech Republic
Statistic Unit Institute for Clinical and Experimental Medicine Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045153
- 003
- CZ-PrNML
- 005
- 20200113135907.0
- 007
- ta
- 008
- 200109s2018 dk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/ctr.13443 $2 doi
- 035 __
- $a (PubMed)30408245
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a dk
- 100 1_
- $a Hubacek, Jaroslav A $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 245 14
- $a The fat mass and obesity related gene polymorphism influences the risk of rejection in heart transplant patients / $c JA. Hubacek, J. Vymetalova, V. Lanska, D. Dlouha,
- 520 9_
- $a Heart transplantation is a relatively common treatment for end-stage heart failure. The major complication of heart transplantation is organ rejection. Epigenetic could play a role in the pathogenesis of organ rejection, and the FTO gene is a mediator of DNA methylation. We analyzed a tagging FTO SNP rs17817449 in both donor and recipient DNA obtained through 370 heart transplantations. Recipient FTO genotypes were not associated with either type of rejection or with the general increase in the risk of rejection. When compared with patients without a history of rejection, carriers of transplanted hearts with the FTO TT genotype exhibited a significantly increased risk (P = 0.02) of suffering from both types of rejection in comparison to carriers of hearts with at least one G allele (OR; 95% CI = 2.56; 1.15-5.69). Our results suggest that the donor, but not the recipient, FTO genotype could be a significant predictor of acute rejection in heart transplant patients.
- 650 _2
- $a gen pro FTO $x genetika $7 D000071516
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a rejekce štěpu $x diagnóza $x etiologie $x genetika $7 D006084
- 650 _2
- $a přežívání štěpu $7 D006085
- 650 _2
- $a transplantace srdce $x škodlivé účinky $7 D016027
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a jednonukleotidový polymorfismus $7 D020641
- 650 _2
- $a pooperační komplikace $x diagnóza $x etiologie $x genetika $7 D011183
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a rizikové faktory $7 D012307
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Vymetalova, Jevgenija $u Cardio Centre, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Lanska, Vera $u Statistic Unit, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 700 1_
- $a Dlouha, Dana $u Centre for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- 773 0_
- $w MED00001167 $t Clinical transplantation $x 1399-0012 $g Roč. 32, č. 12 (2018), s. e13443
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30408245 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113140239 $b ABA008
- 999 __
- $a ok $b bmc $g 1483422 $s 1083826
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 32 $c 12 $d e13443 $e 20181122 $i 1399-0012 $m Clinical transplantation $n Clin Transplant $x MED00001167
- LZP __
- $a Pubmed-20200109